News for SD BioSensor Inc. (137310.KS)

SD Biosensor strengthens its new product lineup with the POC molecular diagnostic platform M10 Early detection of patients is expected to contribute to the eradication of tuberculosis in high-risk Asian countries SEOUL, South Korea, Dec. 6, 2024 /PRNewswire/ -- SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, announced the signing of a tripartite memorandum of understanding (MOU) for the research and development (R&D) of new products targeting extensively drug-resistant tuberculosis using its Point-of-Care (POC) molecular diagnostic platform 'STANDARD M10' (hereinafter, 'M10'). The MOU was signed with the Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (hereinafter, 'RIT/JATA'), and Korea's International Tuberculosis Research Center (hereinafter, 'ITRC'), at SD Biosensor's Giheung Office on Nov. 28.

A team of officials from the National Center for Communicable Diseases, Mongolia (NCCD), had a tour around the Cheongju and Jeungpyeong Factories of SD Biosensor, a South Korea's global in-vitro diagnostics company, during their visit to Korea. SD Biosensor introduced total diagnostic platforms for liver cancer, cervical cancer, tuberculosis, respiratory diseases, etc. SEOUL, South Korea, Nov. 20, 2024 /PRNewswire/ -- SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, stated that the National Center for Communicable Diseases, Mongolia (NCCD), visited SD Biosensor's Cheongju and Jeungpyeong Factories on November 8 and that the NCCD and SD Biosensor discussed cooperation measures to eradicate infectious diseases.

/PRNewswire/ -- SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, stated that the National Center for Communicable Diseases,...

Global POC fentanyl test kits market to grow at 6.0% CAGR by 2030. Vital for swift fentanyl detection amid rising overdose risks. ...

Global demand for point-of-care fentanyl test kits rises amid stricter regulations and growing emphasis on harm reduction. Innovations drive market growth...

Increasing government investments in healthcare and pharmaceutical industries, rising prevalence of cardiovascular diseases, diabetes, etc., and growing...

/PRNewswire/ -- SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, announced on September 15 that it held a proclamation...

Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board...

Ozona, Texas -based Ozona Organics, LLC is recalling select probiotic products for human and animal use citing potential to become contaminated with microbial growth, the U.

/PRNewswire/ -- Frost & Sullivan Institute is proud to present the prestigious Enlightened Growth Leadership Awards, 2023, honoring organizations that embody a...

/PRNewswire/ -- The "South Korea In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players...

/PRNewswire/ -- The

The lateral flow assays market growth driven by rising popularity of point-of-care testing and increasing use of home-based assay kits. The food safety and...

/PRNewswire/ -- Surge in obesity in populace, increase in government initiatives to promote healthy lifestyle and increase in prevalence of cardiovascular...

/PRNewswire/ -- The Frost & Sullivan Institute is dedicated to utilizing business practices to address key global challenges by 'innovating to zero'. Through...